Storys aus Aachen

Fraunhofer-Institut für Produktionstechnologie IPT

Hydrogen technologies at the Hannover Messe 2024: Fraunhofer IPT presents system designs for the production of bipolar plates, MEAs and pressure tanks

agineo GmbH

2

agineo strengthens its international presence with new branches in Europe

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer study report describes AI use cases and sustainable energy concepts

Fraunhofer-Institut für Produktionstechnologie IPT

Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems

Grünenthal Group

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...

Grünenthal Group

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer IPT conducts research into automated series production of optics with new glass press

Grünenthal Group

Grünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration

Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer study report on cybersecurity, digital twins and sustainability in production

Deutsche Hospitality

4

Steigenberger Hotels & Resorts brand coming to Bielefeld

Grünenthal Group

Empowering the Future of Pain Relief Research: Recipients of the 2023 EFIC-Grünenthal Grant Announced

Brussels/Aachen (ots) - - Three promising early-career scientists have been awarded the prestigious EFIC-Grünenthal Grant (E-G-G) 2023. - The E-G-G funds innovative research projects to advance understanding of pain and improve the lives of people suffering from pain. The European Pain Federation EFIC® and the ...

Grünenthal Group

Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee

Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...

Fraunhofer-Institut für Produktionstechnologie IPT

Joint expertise from industry and research: New regulations standardize optical coherence tomography

Grünenthal Group

Grünenthal and King’s College London collaborate to develop human induced pluripotent stem cell-based microfluidic cultures for pain research

Aachen, Germany and London, England (ots) - - Dr Ramin Raouf from King's College London and Grünenthal strive to develop reliable microfluidic culture models relevant for pain research based on human induced pluripotent stem cell-derived neurons - Grünenthal has expertise in developing human induced pluripotent ...

Fraunhofer-Institut für Produktionstechnologie IPT

Go-ahead for 6G in industry: EU funds technology development with more than 13 million euros

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer IPT manufactures super-lightweight frame for experiments in outer space

Grünenthal Group

Janneke van der Kamp starts as new Chief Commercial Officer at Grünenthal

Grünenthal Group

Janneke van der Kamp joins Grünenthal as new Chief Commercial Officer

Grünenthal Group

Grünenthal closes deal to acquire testosterone therapy NebidoTM from Bayer for €495 million

Aachen, Germany (ots) - Grünenthal today announced the successful completion of its acquisition of NebidoTM from Bayer for €495 million. "Testosterone deficiency affects one in six men over 50 years1; representing a significant burden," said Gabriel Baertschi, CEO Grünenthal. "With the completion of this deal, we can now work to bring this meaningful treatment to ...

Accure

HDI TH!NX makes battery reliability insurable on the basis of ACCURE battery analytics

Grünenthal Group

Grünenthal starts Phase III trials for resiniferatoxin in osteoarthritis-related pain

Aachen, Germany (ots) - - Global Phase III programme to enable marketing authorisation in the EU, the US and Japan for an innovative non-opioid investigational medicine. - The programme will be conducted across approx. 200 study sites and include more than 1800 patients suffering from pain associated with osteoarthritis. - Globally, more than 300 million patients ...

Grünenthal Group

Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million

Aachen (ots) - Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal's investigational medicine Resiniferatoxin ("RTX"). Shionogi obtained the exclusive rights to commercialise Grünenthal's asset in Japan for pain associated with osteoarthritis of the knee. RTX ...

Accure

BVG Trials ACCURE’s Battery Safety Monitoring System on Electric Buses

Grünenthal Group

Grünenthal acquires testosterone treatment NebidoTM from Bayer

Aachen, Germany (ots) - - Grünenthal acquires NebidoTM from Bayer AG for up to € 500 million. The product is expected to add about € 100 million to Grünenthal’s EBITDA in 2023. - NebidoTM is the gold standard for the treatment ofmale hypogonadism associated with testosterone deficiency. It is available to patients in over 80 markets worldwide. - Grünenthal has invested over € 2 billion in successful M&A ...

nova-Institut GmbH

4

PRESS RELEASE: Native bast fibres for buses, boards and automotive equipment

Grünenthal Group

Grünenthal, Uniklinik RWTH Aachen and RTWH Aachen University collaborate to advance pain research

Aachen (ots) - Grünenthal, Uniklinik RWTH Aachen and RWTH Aachen University announced a collaboration to advance the development of next-generation pain medicines. The collaboration involves the institutes of Dr Angelika Lampert, Professor of Physiology at the Uniklinik RWTH Aachen and Dr Marc Spehr, ...

Accure

ACCURE exceeds 1,111 megawatt-hours of monitored battery systems with battery-powered boats from Soel Yachts and Naval DC

enua Pharma GmbH

Legalization debate in Germany: Cannabis expert Cannify becomes Enua Pharma GmbH / The start-up has been on the market for four years and is now one of the largest cannabis retailers in Germany

Accure

ACCURE raises $8 million dollars to accelerate the battery safety and analytics market

Ottobock SE & Co. KGaA

2

Dr Bernd Bohr chairs the Supervisory Board for five more years – Stefan Heidenreich joins the Management Board